The brain-computer interface pioneer will set up a regional hub and run clinical trials in its city of origin, Melbourne. Plus news on GLP-1s, genAI and a new MoU.
The brain-computer interface pioneer will set up a regional hub and run clinical trials in its city of origin, Melbourne. Plus news on GLP-1s, genAI and a new MoU.
This content is for paid subscribers only.
Start your free trial nowor purchase a monthly or annual subscription to read.